Prognosis
Russia Begins Making Second Covid-19 Vaccine as Cases Spike
- Vaccine developed by Vector hasn’t completed Phase 3 trials
- Kremlin is bypassing safety protocol to speed development
Photographer: Andrey Rudakov/Bloomberg
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Russia has begun production of a second Covid-19 vaccine that hasn’t completed trials as the Kremlin rushes to develop a shield against the pandemic.